Cabot Wealth Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-17,459	Closed	-$2.14M	–	159
2016 Q3	$2.14M	Sell	17,459 -12,943	-43%	-$1.67M	0.55%	65
2016 Q2	$3.55M	Buy	30,402 +8,215	+37%	+$1.17M	0.93%	40
2016 Q1	$3.09M	Sell	22,187 -1,457	-6%	-$214K	0.86%	49
2015 Q4	$4.51M	Buy	23,644 +123	+0.5%	+$21.5K	1.15%	32
2015 Q3	$3.68M	Buy	23,521 +12,956	+123%	+$2.36M	1.02%	39
2015 Q2	$1.91M	Sell	10,565 -38	-0.4%	-$6.56K	0.46%	79
2015 Q1	$1.84M	Sell	10,603 -11,405	-52%	-$2.06M	0.45%	81
2014 Q4	$4.07M	Sell	22,008 -1,867	-8%	-$346K	1%	46
2014 Q3	$3.96M	Buy	23,875 +261	+1%	+$42.9K	1.01%	41
2014 Q2	$3.69M	Sell	23,614 -398	-2%	-$62.8K	0.93%	47
2014 Q1	$3.65M	Sell	24,012 -13,857	-37%	-$2.2M	0.96%	36
2013 Q4	$5.03M	Sell	37,869 -156	-0.4%	-$18.7K	1.32%	15
2013 Q3	$4.42M	Sell	38,025 -11,974	-24%	-$1.31M	1.32%	13
2013 Q2	$4.61M	Buy	+49,999	New	+$4.82M	1.59%	7